Persica Pharmaceuticals Presents New PP353 Data Supporting Non-Opioid Chronic Low Back Pain Treatment
London, UK – July 24, 2026 Persica Pharmaceuticals has presented new scientific analyses supporting the development of its investigational...
ASPN 2026
Advertisement
Alliance for Building Better Medicine Secures $15.97M EDA Grant
RICHMOND, Va., July 20, 2026 Virginia’s Advanced Pharmaceutical Manufacturing (APM) Tech Hub has secured a $15.97 million investment from...
BIOTRONIK Neuro Launches AI-Powered Embrace One Platform
LAKE OSWEGO, Ore., July 20, 2026 BIOTRONIK Neuro has unveiled Embrace One® Proactive Intelligence, a proprietary artificial intelligence (AI)...
PainTEQ Unveils New SI Joint Clinical Evidence at ASPN
TAMPA, Fla., July 16, 2026 PainTEQ has unveiled new scientific evidence supporting its cortical-piercing posterior sacroiliac (SI) joint fixation...
Akston’s AKS-699 Demonstrates One-Year Pruritus Control with Fewer Treatments
BEVERLY, Mass., June 16, 2026 Akston Biosciences Corporation has announced promising preclinical data demonstrating that its investigational immunotherapeutic AKS-699...
Advertisements
SonoClear Study Selected for EANS 2026 Oral Presentation
OSLO, Norway, June 16, 2026 SonoClear AS has announced that findings from its pivotal multicenter study evaluating the SonoClear®...
Nervonik Completes First Human Nerve Sensing Study
LOS ANGELES, June 16, 2026 Nervonik Inc., a clinical-stage medical device company focused on next-generation neuromodulation technologies, has announced...
Advertisement
